September 16, 2010

An advisory committee of the Food and Drug Administration has given a thumbs-down to a...

September 12, 2010

The Food and Drug Administration did not completely withdraw from the market a drug used...

September 8, 2010

British drug maker Shire is working with Cambridge, Mass.-based Acceleron Pharma to develop treatments for...

August 29, 2010

An investigational relapsing multiple sclerosis drug significantly reduced annualized relapse rate in a late-stage clinical...

August 26, 2010

Pfizer reported mixed results this week in a late-stage clinical trial combining two drugs in...

August 18, 2010

A company that develops drugs for cardiovascular disease has appointed a new leader....

August 18, 2010

Swiss drug maker Biogen Idec will develop and commercialize an investigational drug as a treatment...

August 12, 2010

The companies working on more than half of the mental illness drugs under development are...

August 11, 2010

An investigational biotech drug didn’t significantly improve patients’ survival, according to results of a late-stage...

August 10, 2010

The Food and Drug Administration has approved a late-stage clinical trial of a drug for...

July 22, 2010

An investigational drug for rheumatoid arthritis reduced the duration of symptoms in patients over the...

July 21, 2010

An investigational treatment for HIV made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals works as...

June 29, 2010

Japanese drug maker Eisai has released data on a late-stage clinical trial of a drug...

June 23, 2010

Reports of worsening conditions among patients has led drug maker Pfizer to suspend a clinical...

June 21, 2010

Pfizer has withdrawn one of its cancer drugs from the market at the request of...

June 21, 2010

The use of surrogate endpoints to help measure efficacy in clinical trials would be of...

June 16, 2010

An investigational drug for lupus that could become the first new treatment for the disease...

June 16, 2010

An investigational treatment made by Merck for insomnia was more effective than placebo in improving...

June 15, 2010

The acting chief medical officer for GlaxoSmithKline will lead a phase 3 trial for an...

June 15, 2010

An investigational drug for rheumatoid arthritis significantly reduced symptoms in patients, according to results of...

June 13, 2010

A drug made by Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals failed to extend overall survival...

June 10, 2010

The Food and Drug Administration said Friday it was evaluating data from two clinical trials...

June 9, 2010

Idenix Pharmaceuticals has started a proof-of-concept study of an investigational drug for hepatitis C currently...

June 8, 2010

German drug maker Bayer HealthCare said a 16-year follow-up to a clinical trial of one...